PDGFR Tyrosine Kinase Inhibitor III
PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III), a multikinase inhibitor, inhibits PDGFR, EGFR, FGFR, PKA, and PKC, respectively. PDGFR Tyrosine Kinase Inhibitor III can be used for the research of amyotrophic lateral sclerosis[1].
Product Specifications
CAS Number
[205254-94-0]
Product Name Alternative
PDGF Receptor Tyrosine Kinase Inhibitor III
UNSPSC
12352005
Target
PDGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pdgfr-tyrosine-kinase-inhibitor-iii.html
Purity
99.07
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1CCN(C2=C3C=C(OC)C(OC)=CC3=NC=N2)CC1)NC4=CC=C(OC5=CC=CC=C5)C=C4
Molecular Formula
C27H27N5O4
Molecular Weight
485.53
References & Citations
[1]Young-Min Lee. Compositions and methods for zika virus characterization and vaccine development. WO2019204654A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
